ARTICLE | Targets & Mechanisms
Benztropine for MS
October 31, 2013 7:00 AM UTC
Although the secondary progressive multiple sclerosis space is filling up with new compounds, few have shown the ability to remyelinate neurons. A new study suggests that an ancient Parkinson's disease drug-benztropine-could accomplish that task in secondary progressive multiple sclerosis, although it might require reformulation to improve activity and specificity.1
There are multiple immunomodulatory therapies on the market that stop or slow the autoimmune attack on neurons by myelin-specific ...